Alka-Seltzer Hangover Relief
NDC 0280-0084, ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE, tablet, effervescent, from Bayer HealthCare LLC..
- Product NDC
- 0280-0084
- Status
- Listed
- Labeler
- Bayer HealthCare LLC.
- Dosage form
- TABLET, EFFERVESCENT
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M013
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0084 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CAFFEINE65 mg/1
- ASPIRIN500 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0280-0084-01 | 00280008401 | 10 POUCH in 1 CARTON (0280-0084-01) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-0084-02 | 00280008402 | 18 POUCH in 1 CARTON (0280-0084-02) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-0084-03 | 00280008403 | 60 POUCH in 1 CARTON (0280-0084-03) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-0084-04 | 00280008404 | 2 POUCH in 1 CARTON (0280-0084-04) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-0084-05 | 00280008405 | 1600 POUCH in 1 BOX (0280-0084-05) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-0084-06 | 00280008406 | 30 POUCH in 1 CARTON (0280-0084-06) / 2 TABLET, EFFERVESCENT in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0280-0084 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0084 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0280-0084. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.